A Clinical Study of ONCT-808 in Subjects With Relapsed or Refractory B-Cell Malignancies
Clinical trial NCT05588440 · TERMINATED
Trial details
- NCT number
- NCT05588440
- Sponsor
- Oncternal Therapeutics, Inc
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-09
- Primary completion
- 2024-09-12
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.